Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
- 30 January 2013
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 31 (6), 873-878
- https://doi.org/10.1016/j.vaccine.2012.12.016
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Government of India
This publication has 22 references indexed in Scilit:
- Dengue vaccines: state of the artExpert Opinion on Therapeutic Patents, 2010
- Domain III of the envelope protein as a dengue vaccine targetExpert Review of Vaccines, 2010
- A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaKVaccine, 2009
- Virus-like particles: flexible platforms for vaccine developmentExpert Review of Vaccines, 2007
- Hepatitis B Virus Capsid-like Particles Can Display the Complete, Dimeric Outer Surface Protein C and Stimulate Production of Protective Antibody Responses against Borrelia burgdorferi InfectionPublished by Elsevier BV ,2006
- Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaObstetrics & Gynecology, 2006
- A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formulaEuropean Journal of Immunology, 2005
- Contribution of Disulfide Bridging to Epitope Expression of the Dengue Type 2 Virus Envelope GlycoproteinJournal of Virology, 2004
- HBV Core Particles as a Carrier for B Cell/T Cell EpitopesIntervirology, 2001
- Native display of complete foreign protein domains on the surface of hepatitis B virus capsidsProceedings of the National Academy of Sciences of the United States of America, 1999